top of page


Deepinder Goyal Announces a $25 Million Fund backed by Personal Investment Supporting Research in Aging Biology, Evolution, and Longevity
Continue Research , a 2-year-old research effort to identify and study upstream mechanisms in biology, started by Deepinder Goyal, has announced a $25 million fund to back researchers, funded by personal investment, and is not a part of Eternal. The next breakthroughs in aging biology are hiding in plain sight, emerging not from added complexity but from uncovering foundational mechanisms that control everything downstream. A $25M fund supports researchers testing ideas so si
Karan Bhatia
Oct 24, 20251 min read


How NewLimit Plans to Extend Human Healthspan using Epigenetic Reprogramming
NewLimit , a biotechnology company focused on human longevity, led by Blake Byers, Brian Armstrong, Cathy O'Hare, and Jacob Kimmel, has secured an additional $45 million from Eli Lilly and Company, Duke Management Co., Section 32, and others, bringing its market capitalization to $1.62 billion. Insiders, including Kleiner Perkins, Dimension, Abstract, Human Capital, and Boost, also participated. Significant progress has been made in developing medicines that rejuvenate aging
Karan Bhatia
Oct 22, 20251 min read


Tubulis Raises €308 Million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline
Tubulis , reimagining antibody drug conjugates, led by Dr. Dominik Schumacher, Dr. Jonas Helma-Smets, Dr. Ingo Lehrke, Dr. Günter Fingerle-Rowson, MD, Dr. Björn Hock, Dr. Matthew Norkunas, and others, has secured €308 million (USD 361 million) financing. The round was led by Venrock Healthcare Capital Partners with participation from additional new investors Wellington Management and Ascenta Capital . Existing investors who supported the Series C include Nextech Invest , E
Karan Bhatia
Oct 16, 20252 min read


Nabla Bio Signs Second Takeda Collaboration to Advance AI-Driven Design of Protein Therapeutics
Nabla Bio , making drug development designable with generative AI, led by Surge Biswas, Frances Anastassacos, Rose Harrison, and others, announced a new, multi-year research collaboration with Takeda. Under the agreement, Nabla Bio will receive double-digit millions in upfront and research payments, with potential success-based payments exceeding $1 billion. The collaboration will deploy Nabla Bio’s Joint Atomic Model (JAM) platform across Takeda’s early-stage programs, incl
Karan Bhatia
Oct 15, 20251 min read


How Phagos is Using AI to End Bacterial Disease
Phagos , the sustainable alternative to antibiotics, led by Alexandros Pantalis and Adèle James , has secured 25 million euros Series A...
Karan Bhatia
Oct 8, 20252 min read


Trogenix Advances Clinical Development of Potentially Curative Therapies for Aggressive Cancers
Trogenix Ltd (“Trogenix”), a pioneering biotech company dedicated to developing innovative cancer therapies, led by Prof. Steve Pollard,...
Karan Bhatia
Oct 7, 20251 min read


Until Labs Closes $58 Million in Series A
Until Labs , the company developing reversible cryopreservation for patients in need of donor organs, led by Hunter Davis and Laura...
Karan Bhatia
Sep 23, 20251 min read


DaltonTx Raises £4 Million Seed Financing to Build the Intelligence Backbone of Drug Discovery
DaltonTx , a collaborative intelligence platform redefining how technology powers drug discovery, led by Dr. Garry Pairaudeau, Dr....
Karan Bhatia
Sep 23, 20251 min read


Conceivable Life Sciences Raises $50 Million For AI Automation And Robotic Precision in IVF
Conceivable Life Sciences , the World’s First AI-Powered Automated IVF Lab, led by Joshua Abram, Alan Murray, Alejandro Chavez-Badiola,...
Karan Bhatia
Sep 17, 20251 min read


Genoskin Raises $8.7 Million Series A to Support Drug Development with Ethical, Human-Based Models
Genoskin , bringing unparalleled expertise in skin biology and immunology to advance research and drug development efforts led by Pascal...
Karan Bhatia
Sep 16, 20252 min read


BoobyBiome Raises £2.5 Million to Protect Breast Milk’s Microbiome and Transform Infant Health
BoobyBiome , a startup spun out of University College London’s Great Ormond Street Institute of Child Health, led by Dr Lydia Mapstone,...
Karan Bhatia
Sep 9, 20251 min read


Integra Therapeutics secures €10.7 Million Investment Round to Advance Development of FiCAT Gene Writing Platform and Preclinical Validation of CAR-T Therapies
Integra Therapeutics , a global leader in cutting-edge gene writing tools to improve the efficacy, led by Avencia Sánchez-Mejíasa and...
Karan Bhatia
Sep 8, 20251 min read


NRG Therapeutics Announces Oversubscribed £50m ($67m) Series B Financing to Deliver Clinical Data in Parkinson’s and Proof of Concept in ALS/MND
NRG Therapeutics Ltd. (“NRG”) , an innovative neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, led...
Karan Bhatia
Sep 8, 20251 min read


MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline
MRM Health NV , a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and...
Karan Bhatia
Sep 5, 20251 min read


LIfT BioSciences Announces Grant of €12 Million to Support the First-in-Human Clinical Trial of LIfT’s IMAN Therapy
LIft BioSciences, a rapidly emerging biotech and the global leader in neutrophil immunotherapies, led by Alex Blyth(CEO and Founder),...
Karan Bhatia
Jul 29, 20251 min read


ÄIO Secures €1 Million Public Funding to Develop Fats and Oils for the Cosmetics Industries
AIO, an Estonian Biotechnology Company led by Nemailla Bonturi(Co-Founder and CEO), Petri-Jaan Lahtvee(Co-Founder and COO), Mary-Liis...
Karan Bhatia
Jul 23, 20251 min read


Nudge Secures $100 Million in Series A to Build Whole Brain Interfaces for Everyday Life
Led by Co-Founders Quintin Frerichs and Fred Ehrsam , Nudge raised $100 Million in Series A led by Thrive Capital and Greenoaks ....
Karan Bhatia
Jul 23, 20251 min read


Latent Labs Launches Latent-X, a Frontier Generative AI Model for Protein Binder Design Accessible via No-Code Platform for Push-Button Protein Design
Latent Labs , a company founded by Simon Kohl(Co-developer of Deepmind's AlphaFold2 and co-lead of Deepmind's protein design team), with...
Karan Bhatia
Jul 22, 20252 min read


NUCLIDIUM Closes EUR 84 Million Series B Financing to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform
Led by Dr. Leila Jaafar-Thiel (CEO and Founder), Andreas Schuh(CFO/COO), Ben Pais, MD (CMO), Prof. Dr. Gustav von Schulthess (MD, PhD)...
Karan Bhatia
Jul 11, 20251 min read


Spain-based Portuguese Healthcare Company Biorce Raises €5 Million to Accelerate AI-Powered Clinical Trials
Led by Pedro Coelho(CEO & Founder), Clara Bernardes(Co-Founder & Chief Scientific Officer), Jose Faria(Co-Founder & Head of Engineering),...
Karan Bhatia
Jul 8, 20251 min read
bottom of page